How often does Viridian Therapeutics move more than the options market prices?

2 of the last 8 reports moved at least as far as the implied move.

VRDNNasdaqPharmaceutical Preparations

Viridian Therapeutics, Inc. (VRDN) earnings date, market-implied expected move, and options open interest by expiry

29.05

+3.90 · +15.51%

post 29.62 +1.96%

Closed19:47 ET

Open27.00Volume11.2MMkt cap$3.3B

Day25.68 – 29.62100%52-wk13.18 – 34.2978%

VRDN

Viridian Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Feb 25

before open · in 113 days

est.Q4 FY26

Calendar

Next report

Last report

Nov 4

before open

confirmedQ3 FY26Nov 3 close

Implied vs realized

Largest filed tie

—

Supply chain

Largest filed tie

13F top-10 QoQ

+33.00%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

217 managers

Top fund weight

0.67%

VRDN weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Viridian Therapeutics (VRDN) is expected to report on Feb 25 before open (estimated date).

Implied vs realized

8 reports

2 of 8≥ implied

avg implied: ±19.0%
avg realized: ±9.3%

Nov 12 '24Nov 12 '24confirmed±6.6%▼−12.76%×1.94

Feb 27 '25Feb 27 '25confirmed±21.7%▼−1.55%×0.07

May 6 '25May 6 '25confirmed±32.4%▼−8.31%×0.26

Aug 6 '25Aug 6 '25confirmed±22.0%▼−1.38%×0.06

Nov 5 '25Nov 5 '25confirmed±18.1%▲+8.29%×0.46

Q1 FY26Feb 26 '26confirmed±24.8%▲+1.90%×0.08

May 5 '26May 5 '26confirmed±9.5%▲+33.36%×3.49

Q2 FY26Aug 6 '26confirmed±17.2%▲+6.83%×0.40

quarterimplied−35%0+35%realized×

Q2 FY26±17.2%▲+6.83%×0.40

May '26±9.5%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 3 close

1.19OI · 4 expiries · Nov 3 closeP/C open interest · Apr 16 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

780%Nov 2016d0.18427+20%0.18

2—Dec 1844d0.01134+49%0.01

4860%Jan 1572d0.391,261+1%0.39

report · Feb 25 · before open · est.

138+6%Apr 16163d116−2%

ExpiryPutsCallsP/C

Nov 2016d780%427+20%0.18

Dec 1844d2—134+49%0.01

Jan 1572d4860%1,261+1%0.39

report · Feb 25 · before open · est.

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

−393.01%as filednet margin · revenue +8967.61% QoQ · −63.51% YoY

Revenue$26M+8967.61%

Gross profit$24M94.07%+8429.93%

Operating income−$103M−401.82%+18.05%

Pre-tax income−$103M+17.99%

Net income−$101M−393.01%+20.38%

Cost of revenue$2M—

Operating expenses$128M+0.91%

Other income$198,000−41.59%

Source: SEC filings · standardized · QE Sep 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 19:45 ET

Intraday

Event sensitivity

FOMC ×1.06· ±3.0% vs ±2.8% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±3.0%16 of 24×1.06

NFPjobs report±2.6%5 of 10×0.92

PPIproducer prices±2.3%4 of 10×0.80

CPIconsumer prices±2.2%1 of 10×0.77

CPROFcorporate profits±2.0%7 of 12×0.69

GDPgross domestic product±1.9%12 of 19×0.66

PCEpersonal income & outlays±1.6%10 of 19×0.56

Bar = avg |move| to ±4% · tick = ±2.8% avg day · ×base = |move| ÷ ±2.8% · min 6 releases

Earnings history

EPS -108.33 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	—	-108.33	—
Q2 FY26	Aug 6 '26 · confirmed	-140.49	—
Q1 FY26	Feb 26 '26 · confirmed	-120.94	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod